DK1648906T3 - Organo-silicium-forbindelser og deres anvendelse - Google Patents

Organo-silicium-forbindelser og deres anvendelse

Info

Publication number
DK1648906T3
DK1648906T3 DK04742977T DK04742977T DK1648906T3 DK 1648906 T3 DK1648906 T3 DK 1648906T3 DK 04742977 T DK04742977 T DK 04742977T DK 04742977 T DK04742977 T DK 04742977T DK 1648906 T3 DK1648906 T3 DK 1648906T3
Authority
DK
Denmark
Prior art keywords
organo
silicon compounds
formula
silicon
compounds
Prior art date
Application number
DK04742977T
Other languages
English (en)
Inventor
David John Miller
Graham Andrew Showell
Richard Conroy
Juergen Daiss
Reinhold Tacke
David Tebbe
Original Assignee
Takeda Cambridge Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0316090A external-priority patent/GB0316090D0/en
Priority claimed from GB0402903A external-priority patent/GB0402903D0/en
Priority claimed from GB0411071A external-priority patent/GB0411071D0/en
Application filed by Takeda Cambridge Ltd filed Critical Takeda Cambridge Ltd
Application granted granted Critical
Publication of DK1648906T3 publication Critical patent/DK1648906T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Polymers (AREA)
DK04742977T 2003-07-09 2004-06-18 Organo-silicium-forbindelser og deres anvendelse DK1648906T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0316090A GB0316090D0 (en) 2003-07-09 2003-07-09 Compounds and their use
GB0402903A GB0402903D0 (en) 2004-02-10 2004-02-10 Compounds and their use
GB0411071A GB0411071D0 (en) 2004-05-18 2004-05-18 Compounds and their use
PCT/GB2004/002622 WO2005005443A1 (en) 2003-07-09 2004-06-18 Organosilicon compounds and their use

Publications (1)

Publication Number Publication Date
DK1648906T3 true DK1648906T3 (da) 2008-02-04

Family

ID=34068755

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04742977T DK1648906T3 (da) 2003-07-09 2004-06-18 Organo-silicium-forbindelser og deres anvendelse

Country Status (13)

Country Link
US (1) US20070111967A1 (da)
EP (1) EP1648906B1 (da)
JP (1) JP2007516192A (da)
KR (1) KR20060029282A (da)
AT (1) ATE374778T1 (da)
AU (1) AU2004255913B2 (da)
BR (1) BRPI0412360A (da)
CA (1) CA2531512A1 (da)
DE (1) DE602004009313T2 (da)
DK (1) DK1648906T3 (da)
ES (1) ES2293293T3 (da)
MX (1) MXPA06000371A (da)
WO (1) WO2005005443A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2951026A1 (en) * 2014-06-02 2015-12-10 Chdi Foundation, Inc. Histone deacetylase inhibitors and compositions and methods of use thereof
EP3185881B1 (en) 2014-08-26 2022-03-09 Betanien Hospital Methods, agents and compositions for treatment of inflammatory conditions
WO2019178129A1 (en) 2018-03-13 2019-09-19 Shire Human Genetic Therapies, Inc. Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof
PT4031547T (pt) 2019-09-18 2024-08-27 Takeda Pharmaceuticals Co Inibidores de calicreína plasmática e utilizações dos mesmos
US11370803B2 (en) 2019-09-18 2022-06-28 Takeda Pharmaceutical Company Limited Heteroaryl plasma kallikrein inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141396A0 (en) * 1998-08-20 2002-03-10 Agouron Pharma Non-peptide gnrh agents, methods and intermediates for their preparation
BR0312123A (pt) * 2002-06-13 2005-03-29 Pfizer Agentes de gnrh não peptìdicos, composições farmacêuticas e métodos para o seu uso
ATE334687T1 (de) * 2002-11-20 2006-08-15 Paradigm Therapeutics Ltd Heterozyklische siliziumverbindungen und deren verwendung zur behandlung von krankheiten oder zuständen, die mit gonadotropin-freisetzenden hormon assoziiert sind

Also Published As

Publication number Publication date
CA2531512A1 (en) 2005-01-20
KR20060029282A (ko) 2006-04-05
DE602004009313T2 (de) 2008-01-10
AU2004255913B2 (en) 2007-10-11
JP2007516192A (ja) 2007-06-21
WO2005005443A1 (en) 2005-01-20
AU2004255913A1 (en) 2005-01-20
MXPA06000371A (es) 2006-03-28
EP1648906A1 (en) 2006-04-26
DE602004009313D1 (de) 2007-11-15
BRPI0412360A (pt) 2006-09-05
EP1648906B1 (en) 2007-10-03
ATE374778T1 (de) 2007-10-15
ES2293293T3 (es) 2008-03-16
US20070111967A1 (en) 2007-05-17

Similar Documents

Publication Publication Date Title
CY1106958T1 (el) Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
NO20071127L (no) Triazoloftalaziner
ATE372767T1 (de) Dpp-iv-hemmer
HRP20050228A2 (en) Novel phenanthridines
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
DE60334536D1 (de) Furylverbindungen
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
MXPA05011962A (es) Oxiarenos substituidos.
IN2012DN02609A (da)
TW200600499A (en) Novel amido-substituted hydroxy-6-phenylphenanthridines
SE0103710D0 (sv) Compounds
EA200600607A1 (ru) Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы
NO20062629L (no) Oksazolderivater av tetrackliner
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ATE457982T1 (de) Thiazol-(bi)cycloalkyl-carboxanilide
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
NO20030500L (no) Dihydroporfyrinderivater og deres anvendelse
BRPI0412360A (pt) compostos de organossilìcio e seu uso
ATE461189T1 (de) Neue 6-pyridylphenanthridine
ATE364037T1 (de) Tryptasehemmer
DK1358182T3 (da) Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer